Champions Oncology, Inc. (CSBR)
CSBR moved a median of +0.20% 30 minutes after news, and -0.20% by the close. How CSBR actually reacts to news — the realized, point-in-time move the market made, measured across 130 labeled events over the last three years with zero look-ahead.
CSBR’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 38% | 73 |
| 30-min | +0.20% | 53% | 96 |
| 60-min | +0.18% | 56% | 102 |
| to close | -0.20% | 41% | 128 |
| Middle 50% of CSBR reactions | -0.88% to +1.56% |
|---|---|
| Median reaction (30-min) | +0.20% |
| Measured reactions | 130 |
Half of all Champions Oncology, Inc. news events land between -0.88% and +1.56% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when CSBR moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to CSBR's baseline. Nothing else.
Recent CSBR events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K CHAMPIONS ONCOLOGY, INC. For: Oct 14 | SEC filing · Form 8-K | SEC EDGAR | — | -1.47% | |
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jul 31 | SEC filing · Form 10-Q | SEC EDGAR | — | +0.00% | |
| Champions Oncology Reports Revenue of $15.2 Million | Press release | ACCESS Newswire | -1.72% | -0.39% | |
| Form 8-K CHAMPIONS ONCOLOGY, INC. For: Sep 10 | SEC filing · Form 8-K | SEC EDGAR | -1.72% | -0.39% | |
| Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026 | Press release | ACCESS Newswire | +3.44% | -0.19% | |
| Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging | Press release | ACCESS Newswire | +0.00% | -1.19% | |
| Form DEF 14A CHAMPIONS ONCOLOGY, INC. For: Aug 27 | SEC filing · Form DEF | SEC EDGAR | — | -1.10% | |
| Form DEFA14A CHAMPIONS ONCOLOGY, INC. | SEC filing · Form DEFA14A | SEC EDGAR | — | -1.10% | |
| Champions Oncology Reports Record Annual Revenue of $59 Million | Press release | ACCESS Newswire | -11.27% | -14.66% | |
| Form 10-K CHAMPIONS ONCOLOGY, INC. For: Apr 30 | SEC filing · Form 10-K | SEC EDGAR | -11.27% | -14.66% | |
| Form 8-K CHAMPIONS ONCOLOGY, INC. For: Jul 27 | SEC filing · Form 8-K | SEC EDGAR | -11.27% | -14.66% | |
| Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026 | Press release | ACCESS Newswire | — | +0.00% | |
| Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026 | Press release | ACCESS Newswire | — | +0.52% | |
| Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy | Press release | ACCESS Newswire | — | +0.00% | |
| Form 8-K CHAMPIONS ONCOLOGY, INC. For: Mar 24 | SEC filing · Form 8-K | SEC EDGAR | — | -0.72% | |
| Champions Oncology Reports Revenue of $16.6 Million | Press release | ACCESS Newswire | -0.18% | — | |
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jan 31 | SEC filing · Form 10-Q | SEC EDGAR | -0.18% | +10.71% | |
| Form 8-K CHAMPIONS ONCOLOGY, INC. For: Mar 12 | SEC filing · Form 8-K | SEC EDGAR | -0.18% | +10.71% | |
| Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026 | Press release | ACCESS Newswire | — | — | |
| Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million | Press release | ACCESS Newswire | -6.17% | -13.50% | |
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Oct 31 | SEC filing · Form 10-Q | SEC EDGAR | -6.17% | -13.50% | |
| Form 8-K CHAMPIONS ONCOLOGY, INC. For: Dec 15 | SEC filing · Form 8-K | SEC EDGAR | -6.17% | -13.50% | |
| Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025 | Press release | ACCESS Newswire | — | +0.32% | |
| Form 8-K CHAMPIONS ONCOLOGY, INC. For: Oct 16 | SEC filing · Form 8-K | SEC EDGAR | — | -0.20% | |
| Champions Oncology Reports Record Quarterly Revenue of $14.0 Million | Press release | ACCESS Newswire | +6.00% | +6.00% | |
| CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million | Press release | ACCESS Newswire | +0.84% | +0.72% | |
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jul 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.84% | +0.72% | |
| Form 8-K CHAMPIONS ONCOLOGY, INC. For: Sep 15 | SEC filing · Form 8-K | SEC EDGAR | +0.84% | +0.72% | |
| Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025 | Press release | ACCESS Newswire | -0.78% | +0.15% | |
| Form DEF 14A CHAMPIONS ONCOLOGY, INC. For: Aug 22 | SEC filing · Form DEF | SEC EDGAR | +0.00% | +2.78% | |
| Form DEFA14A CHAMPIONS ONCOLOGY, INC. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | +2.78% | |
| Champions Oncology Reports Record Annual Revenue of $57 Million | Press release | ACCESS Newswire | +0.16% | -1.48% | |
| Form 10-K CHAMPIONS ONCOLOGY, INC. For: Apr 30 | SEC filing · Form 10-K | SEC EDGAR | +0.16% | -1.48% | |
| Form 8-K CHAMPIONS ONCOLOGY, INC. For: Jul 23 | SEC filing · Form 8-K | SEC EDGAR | +0.16% | -1.48% | |
| Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025 | Press release | ACCESS Newswire | +0.00% | -0.86% | |
| Form 8-K CHAMPIONS ONCOLOGY, INC. For: Jul 21 | SEC filing · Form 8-K | SEC EDGAR | — | -0.62% | |
| Champions Oncology Announces Appointment of New CEO | Press release | ACCESS Newswire | +0.00% | -1.84% | |
| Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models | Press release | ACCESS Newswire | -0.11% | -0.79% | |
| Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House | Press release | ACCESS Newswire | -0.06% | -10.74% | |
| Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine | Press release | ACCESS Newswire | +0.00% | -4.28% | |
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jan 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.11% | +9.26% | |
| Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million | Press release | ACCESS Newswire | +8.42% | +8.42% | |
| Form 8-K CHAMPIONS ONCOLOGY, INC. For: Mar 11 | SEC filing · Form 8-K | SEC EDGAR | +1.80% | -4.50% | |
| Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025 | Press release | ACCESS Newswire | +0.00% | -0.40% | |
| Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting | Press release | ACCESS Newswire | -1.73% | -1.82% | |
| Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership | Press release | Accesswire | -1.88% | -7.74% | |
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Oct 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.97% | -8.44% | |
| Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million | Press release | Accesswire | -9.31% | -17.18% | |
| Form 8-K CHAMPIONS ONCOLOGY, INC. For: Dec 11 | SEC filing · Form 8-K | SEC EDGAR | -9.31% | -17.18% | |
| Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024 | Press release | Accesswire | — | +5.25% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the CSBR section they belong to.
Where else CSBR is measured.
CSBR earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ISODIOL INTERNATIONAL INC (ISOLF) | 134 | +0.20% | 52% |
| ContextLogic Inc. (LOGC) | 132 | 0.00% | 40% |
| INNATE PHARMA (IPHYF) | 130 | 0.00% | 0% |
| Deciphera Pharmaceuticals, Inc. (DCPH) | 129 | +0.04% | 55% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Champions Oncology, Inc.'s median reaction calculated?
Every labeled CSBR news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 130 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 53% of CSBR's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does CSBR's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.